LPL Financial LLC Has $2.88 Million Stock Holdings in First Trust Nasdaq Pharmaceuticals ETF $FTXH

LPL Financial LLC raised its holdings in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 87.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 104,902 shares of the company’s stock after acquiring an additional 49,026 shares during the quarter. LPL Financial LLC owned about 19.07% of First Trust Nasdaq Pharmaceuticals ETF worth $2,884,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in FTXH. Envestnet Asset Management Inc. lifted its stake in First Trust Nasdaq Pharmaceuticals ETF by 17.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock valued at $442,000 after acquiring an additional 2,384 shares during the last quarter. Summit Investment Advisors Inc. lifted its stake in First Trust Nasdaq Pharmaceuticals ETF by 13.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 14,173 shares of the company’s stock valued at $382,000 after acquiring an additional 1,633 shares during the last quarter. Vivaldi Capital Management LP lifted its stake in First Trust Nasdaq Pharmaceuticals ETF by 15.6% in the fourth quarter. Vivaldi Capital Management LP now owns 8,677 shares of the company’s stock valued at $243,000 after acquiring an additional 1,171 shares during the last quarter. NBC Securities Inc. raised its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 21,400.0% in the first quarter. NBC Securities Inc. now owns 1,075 shares of the company’s stock valued at $29,000 after purchasing an additional 1,070 shares during the period. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 19.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 16,567 shares of the company’s stock valued at $455,000 after purchasing an additional 2,663 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.5%

NASDAQ:FTXH opened at $27.50 on Monday. First Trust Nasdaq Pharmaceuticals ETF has a 12 month low of $23.28 and a 12 month high of $29.72. The firm has a market cap of $15.12 million, a price-to-earnings ratio of 14.51 and a beta of 0.70. The company’s 50 day moving average is $26.27 and its 200-day moving average is $26.32.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Thursday, June 26th were given a $0.0892 dividend. The ex-dividend date of this dividend was Thursday, June 26th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.3%.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.